Peptide name |
Sequence |
MW |
Ac-[Leu28,31] Neuropeptide Y (24-36), human |
Ac-LRHYLNLLTRQRY-NH2 |
1787.1 |
Neuropeptide AF (hNPAF), Human |
AGEGLNSQFWSLAAPQRF-NH2 |
1978.2 |
Pancreatic Polypeptide Fragment 1-17-[Ala31, alpha-Aminoisobutryl32]-Neuropeptide Y Fragment 18-36 |
APLEPVYPGDNATPEQMARYYSALRHYINLAAibRQRY-NH2 |
4124.7 |
Pancreatic Polypeptide (1-17)-(Ala31,Aib32)-Neuropeptide Y (18-36) (human) |
APLEPVYPGDNATPEQMARYYSALRHYINLAAibRQRY-NH2 |
4209.76 |
Neuropeptide Y(18-36), porcine |
ARYYSALRHYINLITRQRY-NH2 |
2456.9 |
Neuropeptide K, porcine |
DADSSIEKQVALLKALYGHGQISHKRHKTDSFVGLM-NH2 |
3980.6 |
Neuropeptide EI-Gly-Arg-Arg-MCH (human, mouse, rat) |
EIGDEENSAKFPIGRRDFDMLRCMLGRVYRPCWQV |
4186.84 |
Neuropeptide EI, NEI, rat |
EIGDEENSAKFPI-NH2 |
1447.58 |
Xenopsin-related Peptide 2(XP-2) |
FHPKRPWIL |
1193.6 |
Galanin (1 - 13) - Neuropeptide Y (25 - 36), amide, M32 |
GWTLNSAGYLLGPRHYINLITRQRY-NH2 |
2962.4 |
(His32,Leu34)-Neuropeptide Y (32-36) |
HRLRY-NH2 |
742.88 |
Alpha-SG neuropeptide |
IIFTPKL-NH2 |
830.09 |
(Pro30,Tyr32,Leu34)-Neuropeptide Y (28-36) |
INPIYRLRY-NH2 |
1206.46 |
Eledoisin-Related Peptide |
KFIGLM-NH2 |
706.95 |
L-P-L-R-F-NH2 |
LPLRF-NH2 |
643.9 |
Pheromone biosynthesis-activating neuropeptide |
LSDDMPATPADQEMYRQDPEQIDSRTKYFSPRL-NH2 |
3901.33 |
Pheromone biosynthesis-activating neuropeptide II |
LSEDMPATPADQEMYQPDPEEMESRTRYFSPRL-NH2 |
3917.15 |
Bradykinin-Like Neuropeptide (Aplysia californica) |
MKRSRGPSPRR |
1327.58 |
Neuropeptide Y (13-36) (porcine) |
PAEDLARYYSALRHYINLITRQRY-NH2 |
2982.4 |
Neuropeptide Y (13-36), human |
PAEDMARYYSALRHYINLITRQRY-NH2 |
3000.5 |
(Leu31,Pro34)-Neuropeptide Y (13-36) (human, rat) |
PAEDMARYYSALRHYINLLTRPRY-NH2 |
2969.42 |
Neuropeptide F |
PDKDFIVNPSDLVLDNKAALRDYLRQINEYFAIIGRPRF-NH2 |
4593.3 |
FMRF-Like Neuropeptide |
PDVDHVFLRF-NH2 |
1243.5 |
Neuropeptide Y (2-36) (porcine) |
PSKPDNPGEDAPAEDLARYYSALRHYINLITRQRY-NH2 |
4090.53 |
Neuropeptide Y (2-36) (human, rat) |
PSKPDNPGEDAPAEDMARYYSALRHYINLITRQRY-NH2 |
4108.6 |
Eledoisin |
Pyr-PSKDAFIGLM-NH2 |
1188.42 |
Ranatensin |
Pyr-VPQWAVGHFM-NH2 |
1281.5 |
Pheromone biosynthesis-activating neuropeptide I |
RLSEDMPATPADQEMYQPDPEEMESRTRYFSPRL-NH2 |
4073.34 |
Bradykinin-Like Neuropeptide (3-11) (Aplysia californica) |
RSRGPSPRR |
1068.21 |
Neuropeptide Y (22-36), porcine |
SALRHYINLITRQRY-NH2 |
1903.2 |
Neuropeptide Y (3-36), porcine |
SKPDNPGEDAPAEDLARYYSALRHYINLITRQRY-NH2 |
3993.4 |
Neuropeptide Y (3-36), human |
SKPDNPGEDAPAEDMARYYSALRHYINLITRQRY-NH2 |
4011.5 |
Beta-SG neuropeptide |
SLAYDDKSFENVEFTPRL-NH2 |
2130.36 |
NPSF (1-37), Neuropeptide SF (1-37) |
SLNFEELKDWGPKNVIKMSTPAVNKMPHSFANLPLRF-NH2 |
4257 |
Short neuropeptide F |
SNRSPSLRLR F-NH2 |
1332.54 |
Beta-SG neuropeptide |
SVAKPQTHESLEFIPRL-NH2 |
1951.27 |
Gamma-SG neuropeptide |
TMNFSPRL-NH2 |
964.61 |
Gamma-SG neuropeptide |
TMSFSPRL-NH2 |
937.14 |
Alpha-SG neuropeptide |
VIFTPKL-NH2 |
816.06 |
Neuropeptide Y, sheep |
YPSKPDNPGDDAPAEDLARYYSALRHYINLITRQRY-NH2 |
4255.71 |
[Leu31, Pro34]-Neuropeptide Y, porcine |
YPSKPDNPGEDAPAEDARYYSALRHYINLLTRPRY-NH2 |
4109.5 |
[Pro34] Neuropeptide Y, porcine |
YPSKPDNPGEDAPAEDLARYYSALRHYINLITRPRY-NH2 |
4222.7 |
Neuropeptide Y, porcine, Free Acid |
YPSKPDNPGEDAPAEDLARYYSALRHYINLITRQRY |
4254.7 |
Neuropeptide Y, porcine |
YPSKPDNPGEDAPAEDLARYYSALRHYINLITRQRY-NH2 |
4253.7 |
[Leu31,Pro34] Neuropeptide Y (1-36), porcine |
YPSKPDNPGEDAPAEDLARYYSALRHYINLLTRPRY-NH2 |
4222.7 |
Neuropeptide Y (1-24) amide (human, rat) |
YPSKPDNPGEDAPAEDMARYYSAL-NH2 |
2656.87 |
Neuropeptide Y (1-24), human |
YPSKPDNPGEDAPAEDMARYYSAL-NH2 |
2657.1 |
[Pro34] Neuropeptide Y (1-36), human |
YPSKPDNPGEDAPAEDMARYYSALRHYINLITRPRY-NH2 |
4240.8 |
Neuropeptide Y, free acid, human, rat |
YPSKPDNPGEDAPAEDMARYYSALRHYINLITRQRY |
4272.7 |
Neuropeptide Y, human |
YPSKPDNPGEDAPAEDMARYYSALRHYINLITRQRY-NH2 |
4271.8 |
[Leu31,Pro34] Neuropeptide Y, human |
YPSKPDNPGEDAPAEDMARYYSALRHYINLLTRPRY-NH2 |
4240.8 |
[Thr30]-Neuropeptide Y, human |
YPSKPDNPGEDAPAEDMARYYSALRHYINTITRQRY-NH2 |
4259.7 |
Tyr-W-MIF-1 |
YPWG-NH2 |
520.59 |
Neuropeptide F |
YSQVARPRF-NH2 |
1122.31 |